Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
4
×
financing
4
×
life sciences
national blog main
biotech
drug development
startups
venture capital
boston
cancer
detroit blog main
detroit top stories
fda
funding
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
series a
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
20/20 healthcare partners
abbvie
accelerator
accent therapeutics
access biotechnology
access industries
aducanumab
airbnb
alzheimer's disease
What
new
companies
activity
admits
advance
ago
anemia
approvals
associated
big
bio
biogen
biotechs
blood
body
carry
cells
clamped
classes
combinator
covid
delays
develop
developing
device
dialysis
disc
disease
diseases
drugs
dug
economic
enclear
fast
fda
harmful
having
health
including
incubator
Language
unset
Current search:
financing
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
